4
Changes in Ownership
Vanda Pharmaceuticals Inc. Filed Acc 0001209191-21-020782
Chief Corp. Affairs Officer sold 18,000 shares at $17.72 ($319,010)
- Chief Corp. Affairs Officer acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Jones Aranthan II · Chief Corp. Affairs Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-15 | Exercise or conversion : show line 1 in the form | +15,000 | $11.32 | $169,800 | 111,935 | D |
| 2021-03-15 | Sale : show line 2 in the form | −18,000 | $17.72 | $319,010 | 93,935 | D |
| Open-market sales · 18,000 sh · avg $17.72 · $319,010 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-15 | Exercise or conversion : show line 3 in the form Employee Stock Option (Right to Buy) | −15,000 | 55,000 | D |
Loading xslF345X03/doc4.xml…